Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants is a research paper published in PLOS Global Public Health (2024). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Wellcome Trust
Grant: 226137/Z/22/Z
EDCTP
Grant: TMA2016SF-1535-CaTCH-22
EDCTP
Grant: TMA2017SF-1951-TB-SPEC
Bill and Melinda Gates Foundation
Grant: INV-030570
Bill and Melinda Gates Foundation
Grant: INV-046743
South African Medical Research Council
Grant: 96833
South African Medical Research Council
Grant: D2112300-01
National Institute of Allergy and Infectious Diseases
Grant: 75N93021C00016
National Institute of Allergy and Infectious Diseases
Grant: 75N93019C00065
National Institutes of Health
Grant: 3UM1AI068614-15S2
CoVPN 3005 - Efficacy, Immunogenicity, and Safety of SARS-CoV-2 Recombinant Protein Vaccine with Adjuvant in Adults 18 Years of Age and Older
Wellcome Trust
Grant: 226137
Adaptive responses to SARS-CoV-2 variants in the context of hybrid immunity and immune impairment
European Commission
Grant: 101046041
EU-Africa Concerted Action on SAR-CoV-2 Virus Variant and Immunological Surveillance
Fields of Study
Keywords